1. Home
  2. Browse Decisions
  3. F.3d
  4. 848 F.3d
  5. 848 F.3d 981 (2017)
 

SHIRE DEVELOPMENT, LLC v. WATSON PHARMACEUTICALS

2016-1785.

848 F.3d 981 (2017)

SHIRE DEVELOPMENT, LLC, Shire Pharmaceutical Development, Inc., Cosmo Technologies Limited, Giuliani International Limited, NKA Nogra Pharma Limited, Plaintiffs-Appellees v. WATSON PHARMACEUTICALS, INC., NKA Actavis, Inc., Watson Laboratories, Inc. — Florida, NKA Actavis Laboratories FL, Inc., Watson Pharma, Inc., NKA Actavis Pharma, Inc., Watson Laboratories, Inc., Defendants-Appellants.

United States Court of Appeals, Federal Circuit.

Decided: February 10, 2017.

Attorney(s) appearing for the Case

EDGAR HAUG , Frommer Lawrence & Haug LLP, New York, NY, argued for plaintiffs-appellees. Also represented by ELIZABETH MURPHY , ERIKA SELLI , JASON AARON LIEF , ANDREW S. WASSON.

STEVEN ARTHUR MADDOX , Maddox Edwards, PLLC, Washington, DC, argued for defendants-appellants. Also represented by JEREMY J. EDWARDS , KAVEH SABA.

Before Prost, Chief Judge, Taranto and Hughes, Circuit Judges.

Plaintiffs (collectively, Shire) sued Defendants (collectively, Watson) for infringing claims 1 and 3 of U.S. Patent No. 6,773,720 by filing Abbreviated New Drug Application No. 203817 with the Food and Drug Administration seeking to market a generic version of Shire's mesalamine drug, LIALDA®. Because Watson's ANDA Product...

Let's get started

Leagle.com

Welcome to the leading source of independent legal reporting
Sign on now to see your case.
Or view more than 10 million decisions and orders.

  • Updated daily.
  • Uncompromising quality.
  • Complete, Accurate, Current.

Listed below are the cases that are cited in this Featured Case. Click the citation to see the full text of the cited case. Citations are also linked in the body of the Featured Case.

Cited Cases

  • No Cases Found

Listed below are those cases in which this Featured Case is cited. Click on the case name to see the full text of the citing case.

Citing Cases